B-73 | MitraClip® vs Medical Therapy: Updated Meta-Analysis Highlights Significant Mortality Advantage
Prior randomized trials have reported conflicting results regarding optimal treatment strategy for functional mitral regurgitation (FMR). This meta-analysis aims to compare mortality outcomes between Transcatheter Mitral Valve Repair using MitraClip® and medical therapy (MT) in patients with FMR.
Authors
- Kim I. de la Cruz (ORCID: https://orcid.org/0000-0003-1089-2797)
- Ashish Verma (ORCID: https://orcid.org/0000-0001-7722-4959)
- Kishore J. Harjai (ORCID: https://orcid.org/0000-0001-9441-296X)
- Eric A. Stein
- Joel Thekekara (ORCID: https://orcid.org/0000-0003-1284-2881)
- Ajmal Khan (ORCID: https://orcid.org/0000-0002-4727-3554)
- Sanskriti Shrivastava (ORCID: https://orcid.org/0000-0002-4563-4758)
- Mina Mehanni
- Shilpkumar Arora (ORCID: https://orcid.org/0000-0002-7246-7262)
- Rohan Agarwal (ORCID: https://orcid.org/0009-0000-3525-5765)
- Abdalla Hassan
- Oliver Chrisler
- Venkata P. Peddada
- Divya Ratan Verma
- Steven C. Smart
- Akhila Bhim
Institutions
- Hannibal–LaGrange University (US)
- Saint Louis University Hospital (US)
- Banner - University Medical Center Phoenix (US)
- Chesterfield Royal Hospital (GB)
- SSM Health Rehabilitation Hospital (US)
- Vitalant (US)
- Saint Louis University (US)
Publication Details
- Journal
- Journal of the Society for Cardiovascular Angiography & Interventions
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1016/j.jscai.2025.102946
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00